baber/WOPTO huggingface dataset:
Patent JP-3046645-B2 (JP)
IPC: F16C33/64
Filed: 1991-05-30
Granted: 2000-05-29
Abstract: PURPOSE:To divide a bearing ring with flange at a desired dividing surface securely without generating notch or the like. CONSTITUTION:A ring-shape outer wheel 1 having flanges 1 in the side edges thereof is manufactured. Notches 6 by the width of the flange 1 are provided in the side edges of this outer wheel 2, and a dividing groove 7 following the notches 6 on both sides is formed in a mark shape on the inner diameter surface serving as the travelling surface side of the outer wheel 2. Thereafter, a radial directional load is applied to the outer wheel 2 by pressure members 8, 9 so as to divide the outer wheel naturally in the axial direction along the dividing groove 7.
Patent JP-2643943-B2 (JP)
IPC: C07J1/00
Filed: 1987-07-13
Granted: 1997-08-25
Abstract: The invention relates to new 6- or 7-methylenandrosta-1,4-diene-3,17-diones of the following formula <CHEM> wherein R is hydrogen or fluorine; R1 is hydrogen or C1-C6 alkyl; R2 is hydrogen or halogen; one of R3 and R4 is =CH2 and the other is hydrogen or C1-C4 alkyl, and when R3 is =CH2, at least one of R and R4 is other than hydrogen; and the symbol @ @@ represents a double bond and the symbol @@@ represents a single bond when R3 is =CH2 or the symbol @@@ represents a single bond and the symbol @@@ represents a double bond when R4 is =CH2, which are useful in therapy, in particular as anti-cancer agents.
Patent JP-2550356-B2 (JP)
IPC: A61K47/00
Filed: 1987-07-16
Granted: 1996-11-06
Abstract: An aqueous solution containing a bacterially effective concentration of taurolidine and/or taurultam together with a parenterally acceptable polyol. The aqueous solution is particularly suitable for parenteral administration.
Patent JP-H0141631-B2 (JP)
IPC: A01N43/64
Filed: 1980-12-17
Abstract: New substituted triazolylmethyl tert.-butyl ketones of the formula <IMAGE>   in which R represents alkyl, alkenyl, alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl or optionally substituted aralkyl, X represents hydrogen or halogen and Y represents halogen, and the acid addition salts and metal salt complexes thereof, a process for the preparation of said novel compounds, their use as plant protection agents and as intermediate products for the synthesis of other plant protection agents.
Patent JP-H0356067-B2 (JP)
IPC: A61M29/02
Filed: 1986-07-30
Abstract: A self-venting balloon dilatation catheter (10) having a flexible tubular, member with first (13) and second (16) lumens extending therethrough. An inflatable balloon (17) is carried by the distal extremity of the tubular member in such a manner that the first lumen (13) extends through the balloon (17) and is out of communication with the interior of the balloon (17) and the second lumen (10) is in communication with the interior of the balloon (17). A venting device (21) is disposed between the balloon (17) and the tubular member (12) for venting air from the interior of the balloon (17) but inhibiting the escape of liquid from the balloon (17).
Patent JP-H0542408-B2 (JP)
Inventor: BIBEKE RESU
IPC: A01N63/30
Filed: 1984-09-06
Abstract: Disease causing material obtainable by cultivation of Phomopsis cirsii or Septoria cirsii can be used for controlling weeds such as compositae.
Patent JP-2598134-B2 (JP)
IPC: G05D7/06
Filed: 1989-08-04
Granted: 1997-04-09
Abstract: A flow rate control system is disclosed for measurement of ink flow through an ink jet system. The flow rate control system receives an error signal indicative of deviation of flow rate from a set value. The system includes proportional (P), integral (I) and derivative (D) control to generate a control signal based on the magnitude and sign of the error signal. The control signal is used to control the on-time of an ink make-up valve which adds make-up ink to the system as ink is needed to maintain satisfactory operation. In a preferred embodiment, the PID controller has noise reduction capability through the use of clippers and low pass filters. In addition, conditional summation may be employed to minimize "hunting" at low error signal levels.
Patent JP-3086228-B2 (JP)
IPC: G02F1/13
Filed: 1989-08-22
Granted: 2000-09-11
Abstract: This invention relates to nematic liquid crystal compositions for both passive and active matrix liquid crystal display devices and to liquid crystal display devices fabricated therefrom. The composition of the invention contains at least one compound represented by general formula (I), wherein R1 represents an alkyl group having 1 to 10 carbon atoms, A represents (a) or (b), l is an integer of 1 or 2, and m is an integer of 0 or 1, provided that the sum of l and m is 2.
Patent JP-2776770-B2 (JP)
IPC: A61K8/00
Filed: 1995-09-06
Granted: 1998-07-16
Abstract: A cpd. with a gp. carrying ≥ 1 chelating function for a transition metal, blocked by a substit. which can be cleaved by light, is used as chelating agent for a transition metal. The chelating gp. is an amine, carbonyl, CN, oxime, COOH, OH, hydroxamic, alkoxide, enolic, phenolic, phenoxide, hydrazide and/or S gp., esp. a hydroxypyridinone, a dicarboxylic amine, an o-hydroxybenzylamine or a hydroxamate. The photocleavable gp. is p-methoxyphenacyl (pref.), 2-nitrobenzyl (pref.), 2-nitrobenzyloxycarbonyl, 2-nitrophenylethylene glycol, benzyloxycarbonyl, 3,5-dimethoxybenzyloxy-carbonyl,  alpha , alpha -dimethyl- 3,5-dimethoxybenzyloxy-carbonyl, 3-nitrophenyl, 3-nitrophenyloxy, 3,5-dinitrophenyloxy, 3-nitrophenyloxy-carbonyl, phenacyl, 4-methoxyphenacyl),  alpha -methylphenacyl, 3,5-dimethoxybenzoinyl or 2,4-dinitro-benzene sulphenyl. The transition metal has atomic number 21-30, and is pref. Fe or Cu.
Patent JP-H0549677-B2 (JP)
Inventor: HERUMUUTO BIIRE
IPC: C07F9/40
Filed: 1991-09-12
Abstract: Diphosphonic acid derivatives of Formula I    <IMAGE>  (I)  wherein R is hydrogen, an alkali metal atom, an alkaline earth metal atom, or an alkyl group of 1-4 carbon atoms and A is derived from a carboxylic acid having anti-inflammatory and antiphlogistic activity and containing an aromatic or heteroaromatic group, of Formula II ACOOH (II),  are pharmacologically efficacious compounds.
Patent JP-3948168-B2 (JP)
IPC: H01H11/00
Filed: 1999-08-23
Granted: 2007-07-25
Abstract: An object is to provide a key protection structure for an electronic apparatus which can prevent a preset value of a switch from being intentionally changed by the user or the like.  When setting of a first switch 21 is ended, a tool shutter operation portion 72 of a lock key 70 is inserted into a first shutter operation hole 61. The tool shutter operation portion 72 is then engaged with an engaging recess 45 of a first shutter 40. Thereafter, the lock key 70 is rotated, so that the first shutter 40 is rotated. A covering portion 44 of the shutter is therefore moved immediately above the first switch 21 to close a first switch operation hole 58, whereby the first switch 21 can be locked (key-protected) so as not to be externally operated.
Patent JP-2989649-B2 (JP)
IPC: H04N1/36
Filed: 1990-09-25
Granted: 1999-12-13
Abstract: A signal generating means for generating predetermined picture clock signals for transferring picture information, and a selecting means for selecting either the predetermined picture clock signal generated from the signal generating means or the picture clock signal which is generated from the signal generating means and is returned via an editing device, are provided on a copying device side. When the predetermined picture clock signal for transferring picture information is generated from the signal generating means, by the selecting means, either the predetermined picture clock signal generated from the signal generating means or the picture clock signal which is generated from the signal generating means and is returned via the editing device, is selected. The clock is made to be usable as a common clock signal to the transfer of the picture information read out from a means for reading out pictures and the transfer of the picture information outputted from the editing device. <IMAGE>
Patent JP-3413255-B2 (JP)
IPC: A24C5/20
Filed: 1993-10-27
Granted: 2003-06-03
Abstract: The invention relates to a device for feeding a wrapping strip (11a, 11b), in a tow machine in the tobacco processing industry, for a tow (4a, 4b) which may consist of smokable material or filter material, and is conveyed by a tow conveyor belt (3a, 3b). The problem underlying the invention comprises ensuring reliable entrainment of the start of the wrapping strip to the garniture of the machine, in which the tow is wrapped with the wrapping strip. According to the invention, the problem is solved in that a displacement element (21a, 21b) is provided which can be activated, when the start of the wrapping strip is fed, to reduce the distance between the tow conveyor belt and the wrapping strip. As a result of the invention, simple threading of wrapping strips and reliable entrainment of the start of the wrapping strip are guaranteed. <IMAGE>
Patent JP-H0478868-B2 (JP)
IPC: F16H61/08
Filed: 1987-10-30
Abstract: A one-way valve is arranged with an accumulator in a manner wherein the discharging of the accumulator is restricted. During upshifting, the stroking of a band brake servo in a release direction is induced before the charging stroke of the accumulator and the appropriate timing of the engagement of a high clutch (H/C) and the disengagement of a band brake (B/B) is induced. During downshifting, the pressure which is prevailing in the conduiting interconnecting the two friction elements is allowed to drop rapidly during the initial stage of the shift due to the provision of the one-way orifice (110) and allows the torque transmission capacity of the clutch to quickly reduce while inducing the stroking of the band brake servo in an engaging direction before the discharge stroke of the accumulator.
Patent JP-2779435-B2 (JP)
IPC: G10L25/00
Filed: 1995-10-31
Granted: 1998-07-23
Abstract: PROBLEM TO BE SOLVED: To provide noise reduction capacity additionally without requiring any phase matching processing by calculating a cross spectral matrix using a prediction coefficient matrix thereby determining a frequency spectrum. SOLUTION: A receiver group 50 comprises M receivers for converting an acoustic signal from a vessel or the like into an electric signal. A frequency analysis section 60 calculates a cross correlation matrix from cross correlation coefficients in M receiving signals being inputted to a cross correlation matrix calculating section 61 from the receiver group 50. A prediction coefficient matrix calculating section 62 calculates a prediction coefficient matrix by applying a multivariate linear prediction analysis to the cross correlation matrix. Based on prediction coefficient matrix, a cross spectral matrix calculating section 63 calculates a cross spectral matrix for each frequency to be analyzed.  A frequency spectrum detecting section 64 calculates a frequency spectrum from a cross spectral matrix for each frequency to be analyzed and the frequency spectrum is presented on a display section 70 depending on the intensity thereof. According to the arrangement, noise reduction capacity can be added without requiring any phase matching processing.
Patent JP-3476851-B2 (JP)
IPC: G10L19/00
Filed: 1992-10-28
Granted: 2003-12-10
Abstract: PURPOSE:To prevent unnatural edit such as the erasure start or inserttion on the halfway of recording from occurring when a series of recorded voice information are edited. CONSTITUTION:This editor is equipped with a detecting means 3 which detects a silent part in a series of recorded voice information, an instruction means 3 which instructs the editing part of a series of recorded voice information, and control means 2, 3, and 6 which receive an instruction from the instruction means 1 and edit the voice information setting the silent part as reference when the fact that an instructed point is the silent part is detected by the detecting means 3, and the silent part nearest to the instructed point before the instructed point as reference when the instructed point is not the silent part.
Patent JP-3568550-B2 (JP)
IPC: A61K8/34
Filed: 1992-10-06
Granted: 2004-09-22
Abstract: A single-stage process for dyeing keratinous fibers in intense colors comprising simultaneously applying to said keratinous fibers a composition comprising iodide ions, an oxidant and an effective concentration of an oxidation dye to produce said intense colors when the pH of said composition is alkaline. <IMAGE>
Patent JP-2891732-B2 (JP)
IPC: B01D39/14
Filed: 1989-12-28
Granted: 1999-05-17
Abstract: Filter, in particular absolute filter for supplying an even flow directed at work stations to keep the air clean. The filter matrix is provided with a fine mesh air penetratable sheet material (6) on the outlet side. In this way possible directional differences in the flow in the filter is eliminated and an even flow obtained.
Patent JP-3212298-B2 (JP)
IPC: B41F13/004
Filed: 1999-12-21
Granted: 2001-09-25
Abstract: A system is presented for synchronous control of rotary printing presses comprising a master control section (1) for controlling the entire system, a plurality of printing units (CT1-CT5) and a folding unit (FD) for cutting and folding a printed paper web (W1-W5) into predetermined printed images, drive means (M) for independently driving the units, and control sections for controlling the drive means for driving the printing units. At least one printing unit has a plurality of web paths running from the printing unit in question to the folding unit, and printing is accomplished by threading the printed paper web through any of the web paths . <IMAGE>
Patent JP-2509315-B2 (JP)
Inventor: AASLYNG DORRIT ANITA
IPC: C12N9/52
Filed: 1987-11-25
Granted: 1996-06-19
Abstract: PCT No. PCT/DK87/00144 Sec. 371 Date Aug. 30, 1988 Sec. 102(e) Date Aug. 30, 1988 PCT Filed Nov. 25, 1987 PCT Pub. No. WO88/03947 PCT Pub. Date Jun. 2, 1988.Novel alkaline serine proteases produced by Nocardiopsis sp. strains, for example by aerobic cultivation of strain 10R (NRRL-18262) and Nocardiopsis dassonvillei strain M58-1 (NRRL 18133), the proteases being characterized by a pH optimum of about 8, and by retention of at least 60% of maximum activity at pH 7-11 measured with casein as substrate. The proteases of the invention may be distinguished from the known protease of the Nocardiopsis strain ZIMET 43647 (of East German 2004328) and known Bacillus and fungal alkaline proteases. The Alkaline proteases of strains 10R and M58-1 may also be distinguished from each other. The protease preparations of this invention are useful detergent additives for cold water laundering.
Patent JP-4335309-B2 (JP)
IPC: C12N15/09
Filed: 1996-04-23
Granted: 2009-09-30
Abstract: This invention relates to plasmid constructs useful for nonviral human gene therapy. The plasmid constructs incorporate plasmid elements for achieving high copy number, avoiding plasmid instability an providing a plasmid selection process. These constructs can be used to deliver nucleic acids to cells in vehicles which are compatible with human therapeutic use.
Patent JP-H0780775-B2 (JP)
IPC: A61P25/28
Filed: 1987-02-12
Abstract: PCT No. PCT/EP87/00068 Sec. 371 Date Oct. 8, 1987 Sec. 102(e) Date Oct. 8, 1987 PCT Filed Feb. 12, 1987 PCT Pub. No. WO87/05024 PCT Pub. Date Aug. 27, 1987.Pharmaceutical compositions active on cerebral metabolism and on neuronal transmission containing as the active principle glycerophosphoryl-O-serine.
Patent JP-2726156-B2 (JP)
IPC: C21B11/02
Filed: 1991-12-23
Granted: 1998-03-11
Abstract: PCT No. PCT/EP91/02501 Sec. 371 Date Oct. 27, 1993 Sec. 102(e) Date Oct. 27, 1993 PCT Filed Dec. 23, 1991 PCT Pub. No. WO92/12265 PCT Pub. Date Jul. 23, 1992.A method of reducing metal oxides in a vessel containing a molten bath, the bath comprising a metal layer and a slag layer, wherein metal oxides and carbonaceous material are introduced into the bath, gas is injected into the slag layer to case the eruption of molten slag parts, droplets and/or streams into the gas space above the bath and oxygen-containing gas is injected into the gas space to case post-combustion.
Patent JP-3182154-B2 (JP)
IPC: C07F7/20
Filed: 1997-06-11
Granted: 2001-07-03
Abstract: PCT No. PCT/FR97/01034 Sec. 371 Date Sep. 7, 1999 Sec. 102(e) Date Sep. 7, 1999 PCT Filed Jun. 11, 1997 PCT Pub. No. WO97/47629 PCT Pub. Date Dec. 18, 1997Improved method for obtaining organosilanes comprising: a redistribution reaction between a chlorinated organohydrogenosilane and an organo-substituted and optionally chlorinated silane, the distribution reaction taking place in the presence of a sufficient amount of a catalyst consisting of a Lewis acid of formula (3) M(X)d in which: M represents a metal selected among Ti, Fe, Cu, Ag, Zn, Cd, Hg, Al, Ga, In, B, Sn, Pb, Sb, and Bi; X represents a halogen atom; d represents the valency of metal M; and separation by distillation of the chlorinated organohydrogenosilane produced by redistribution; the said method being characterized in that, after redistribution, a redistribution catalyst inhibiting compound is used. This catalyst is selected among the fluid polyorganosiloxanes (POS) having a viscosity at 25 DEG  C. not exceeding 5000 mPa.s and is used in such proportions that the ratio r=number of gram-atoms of metal M given by the catalyst/number of gram-atoms of oxygen given by the inhibitor does not exceed 0.9.
Patent JP-3594970-B2 (JP)
IPC: A61K6/083
Filed: 1995-06-13
Granted: 2004-12-02
Abstract: Use of a composition comprising a component which is a liquid reaction product obtained by reacting one mole of a 4,4'-oxydiphtalic anhydride (5,5'-oxybis-1,3-isobenzo furandione) with two moles of one or more compounds of the general formula ROH, wherein R is a polymerizable unsaturated moiety having from 2 to 13 carbon atoms in the presence of an acid, base or suitable catalyst for the preparation of a dental restorative composition for binding to hard tooth, metal and ceramic.
Patent JP-3234927-B2 (JP)
IPC: A61L31/10
Filed: 1993-05-12
Granted: 2001-12-04
Abstract: The present invention provides an improved coextruded medical grade port tubing. The medical grade port tubing provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. To this end, the present invention provides a non-PVC coextruded medical grade port tubing including: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer; and a core layer including a blend of polyamide and ethylene vinyl acetate.
Patent JP-H0789931-B2 (JP)
IPC: A61K39/21
Filed: 1985-08-22
Abstract: Disclosed is the molecular cloning of HTLV-III, the adult leukemia and acquired immune deficiency syndrome (AIDS) virus. Clone BH10 contains a 9.0 Kb viral insert constituting the entire HTLV-III genose. Clones BH8 and BH5 contain viral inserts of 5.5 Kb and 3.5 Kb, respectively. These clones are suitable for the development of diagnostic and therapeutic measures for AIDS, as well as use as probes for the detection of AIDS.
Patent JP-2651748-B2 (JP)
IPC: F03G7/00
Filed: 1994-07-07
Granted: 1997-09-10
Abstract: An electrochemical actor with a closed gas chamber has a plurality of stacked cells (7), each of which contains a solid electrode of an electrochemically reversibly oxidisable material and a gas-generating or consuming counter-electrode, whereby a rise of fall in pressure convertible in one movement is effected by a reversible d.c.-generated electrochemical reaction cycle in the gas chamber. To limit the gas formation and vertical movement there is a mechanically actuatable electric switch, the actuating member (14) of which is arranged in the path of movement of an adjuster (4) to which gas pressure is applied in such a way that, when the adjuster (4) reaches a predetermined end position, the connecting line to the d.c. source is interrupted.
Patent JP-3648251-B2 (JP)
IPC: C07D401/02
Filed: 1996-08-29
Granted: 2005-05-18
Abstract: Novel piperidine derivatives, their manufacture and use as medicaments, are disclosed. The invention is concerned with the novel piperidine derivatives of general formula I wherein R1, R2, R3, R4, Q, X, Z, m and n are as described herein.
Patent JP-3457004-B2 (JP)
IPC: C07K16/24
Filed: 1995-09-22
Granted: 2003-10-14
Abstract: PCT No. PCT/EP95/03757 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/10041 PCT Pub. Date Apr. 4, 1996The present invention is directed to peptides from the sequence of hPTH(1-37), which contain  alpha -helical amino acid sequence regions and/or non-structured amino acid sequence regions, said peptides being capable of inducing antibodies when injected into animals. Furthermore, the invention is directed to a diagnostic agent and antibodies obtainable by immunizing animals using the peptides according to the invention.
Patent JP-3174328-B2 (JP)
IPC: C12P17/12
Filed: 1992-08-19
Granted: 2001-06-11
Abstract: PCT No. PCT/EP92/01892 Sec. 371 Date Jun. 17, 1994 Sec. 102(e) Date Jun. 17, 1994 PCT Filed Aug. 19, 1992 PCT Pub. No. WO93/04189 PCT Pub. Date Mar. 4, 1993.Arylalkanoic acids are produced by biotransformation using suitable microorganisms and, in particular, (S)-ketoprofen in greater than 95% purity from racemic ketoprofen ethyl ester.
Patent JP-3133326-B2 (JP)
IPC: B42D15/10
Filed: 1991-07-12
Granted: 2001-02-05
Abstract: PCT No. PCT/GB91/01158 Sec. 371 Date Jan. 12, 1993 Sec. 102(e) Date Jan. 12, 1993 PCT Filed Jul. 12, 1991.A transfer film for use, for example, with security documents includes a pattern defining layer having concavities defining an inverted relief pattern, and a retaining layer overlying and releasably filling the concavities of the pattern defining layer. The pattern defining layer is removable from the retaining layer to transfer the relief pattern from the pattern defining layer to the retaining layer.
Patent JP-H0813274-B2 (JP)
IPC: C12Q1/68
Filed: 1991-08-12
Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2'-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of HIV, herpes virus, papillomavirus and other infections is provided.
Patent JP-3825470-B2 (JP)
IPC: D07B1/02
Filed: 1995-10-27
Granted: 2006-09-27
Abstract: PCT No. PCT/EP95/04253 Sec. 371 Date Jun. 27, 1997 Sec. 102(e) Date Jun. 27, 1997 PCT Filed Oct. 27, 1995 PCT Pub. No. WO96/14453 PCT Pub. Date May 17, 1996A process for preparing an alginate rope, which process comprises the steps of: (a) extruding an aqueous solution of a water soluble alginate into a coagulation bath; (b) contacting the extruded water soluble alginate with a source of a cation capable of forming a water insoluble alginate salt so as to produce a tow of water insoluble alginate fibers; (c) twisting the water insoluble alginate fibers of the tow; and (d) stretching the fibers up to 250% of their original length. The alginate rope prepared according to the process of the invention may be used as a surgical pack material or in the treatment of cavity wounds.
Patent JP-3121351-B2 (JP)
IPC: B28B11/02
Filed: 1995-12-05
Granted: 2000-12-25
Abstract: Floor or wall tiles (3) are known in which spacers are formed in one piece with the tiles during manufacture. According to the invention, a production facility for fitting tiles (3) with spacers on an industrial scale is provided with: at least one continuous conveyor system for transporting tiles (3) between different functional devices; an application device (6) for applying spacer material to the tiles (3); a kiln (9) for fusing the spacer material onto the tiles (3); and a cooling area (11, 12) where the spacer material can harden and the tiles can cool. The proposed method and device can be used for laying tiles in a flat tile lattice structure using a jolting or vibration process.